Abstract:Objective: To explore the differentially expressed proteins in normal cervix, cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma (CSCC) tissues by differential proteomics technique. Methods: Cervical tissues (including normal cervix, CIN and CSCC) were collected in Department of Gynecologic Oncology of Beijing Obstetrics and Gynecology Hospital. Two-dimensional fluorescence difference in gel electrophoresis (2-D DIGE) and DeCyder software were used to detect the differentially expressed proteins. Matrix-assisted laser desorption/ionization-time-of-flight tandem mass spectrometry (MALDI-TOF/TOF MS) was used to identify the differentially expressed proteins. Western blot (WB) and immunohistochemistry (IHC) were performed to validate the expressions of selected proteins among normal cervix, CIN and CSCC. Results: 2-D DIGE images with high resolution and good repeatability were obtained. Forty-six differentially expressed proteins (27 up-regulated and 19 down-regulated) were differentially expressed among the normal cervix, CIN and CSCC. 26 proteins were successfully identified by MALDI-TOF/TOF MS. S100A9 (S100 calcium-binding protein A9) was the most significantly up-regulated protein. Eukaryotic elongation factor 1-alpha-1 (eEF1A1) was the most significantly down-regulated protein. Pyruvate kinase isozymes M2 (PKM2) was both up-regulated and down-regulated. The results of WB showed that with the increase in the severity of cervical lesions, the expression of S100A9 protein was significantly increased among the three groups (P = 0.010). The expression of eEF1A1 was reduced but without significant difference (P = 0.861). The expression of PKM2 was significantly reduced (P = 0.000). IHC showed that protein S100A9 was mainly expressed in the cytoplasm, and its positive expression rate was 20.0 % in normal cervix, 70.0 % in CIN and 100.0 % in CSCC, with a significant difference among them (P = 0.006). eEF1A1 was mainly expressed in the cell plasma, and its positive expression rate was 70.0 % in normal cervix, 73.3 % in CIN and 60.0 % in CSCC tissues, without significant difference among them (P = 0.758). PKM2 was mainly expressed in the cell nuclei, and its positive expression rate was 100.0 % in normal cervix, 93.3 % in CIN and 75.0 % in CSCC tissues, showing a difference close to statistical significance (P = 0.059) among them. Conclusions: There are differentially expressed proteins among normal cervix, CIN and CSCC. S100A9, eEF1A1 and PKM2 may become candidate markers for early diagnosis of cervical cancer and new targets for therapy. It also provides a basis for further studies of the mechanism for CIN developing to CSCC.

Separation and Identification of Differentially Expressed Nuclear Matrix Proteins Between Human Esophageal Immortalized and Carcinomatous Cell Lines

Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma

[Differential Expression of STRBP8, a New Candidate Oncogene, in Cancerization of Human Immortalized Esophageal Epithelial Cells].

[Differential Analysis of Two-Dimension Gel Electrophoresis Profiles of Human Lung Squamous Carcinoma and Tumor-Adjacent Tissue].

N-linked glycoproteomic profiling in esophageal squamous cell carcinoma

Comparative Proteomic Analysis of Esophageal Squamous Cell Carcinoma

Proteomic Analysis of Human Esophageal Cancer Using Tandem Mass Tag Quantifications

Proteomics analysis of stage-specific proteins expressed in human squamous cell lung carcinoma tissues.

Identification of Distinct Gene Expression Profiles Between Esophageal Squamous Cell Carcinoma and Adjacent Normal Epithelial Tissues

Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma

Cytogenetic and Molecular Genetic Changes in Malignant Transformation of Immortalized Esophageal Epithelial Cells

Differential mitochondrial proteome analysis of human lung adenocarcinoma and normal bronchial epithelium cell lines using quantitative mass spectrometry

[Differential Proteins in Esophageal Squamous Cell Line EC9706/CDDP Identified by SILAC Quantitative Proteomic Approach].

iTRAQ-Based Quantitative Proteomic Analyses of High Grade Esophageal Squamous Intraepithelial Neoplasia.

Differential Extracellular Matrix Proteomic Signatures in Malignant and Benign Polyps from Appalachian Region Colon Cancer Patients

Immortal Phenotype Of The Esophageal Epithelial Cells In The Process Of Immortalization

Identification of Differentially Expressed Proteins in the Locoregional Recurrent Esophageal Squamous Cell Carcinoma by Quantitative Proteomics

Nano-ESI-MS/MS Identification on Differentiation-associated Proteins in M1 Mouse Myeloid Leukemia Cells Induced by IL-6

Integrated analysis of immune infiltration in esophageal carcinoma as prognostic biomarkers

Identification of Crucial Long Non-Coding RNAs and Mrnas along with Related Regulatory Networks Through Microarray Analysis in Esophageal Carcinoma

Integrated proteomics and phosphoproteomics analyses of esophageal cancer cells with different invasive abilities